Tags

Type your tag names separated by a space and hit enter

Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options?
J Dermatolog Treat. 2010 Nov; 21(6):326-30.JD

Abstract

Broadband ultraviolet B (BB-UVB) phototherapy has demonstrated efficacy in the treatment of cutaneous disorders including psoriasis, atopic dermatitis, uremic pruritus and idiopathic pruritus. In the last decade, there has been a rapidly escalating process of replacing BB-UVB phototherapy units with narrowband ultraviolet B (NB-UVB) equipment, as studies have demonstrated that NB-UVB (ranging from 311 mm to 312 nm) is more efficacious in the treatment of psoriasis. Nevertheless, it is important to recognize the efficacy of BB-UVB phototherapy in the treatment of uremic pruritus, idiopathic pruritus, eosinophilic folliculitis and other inflammatory pruritic conditions. Furthermore, as highlighted in this report, there is a small but significant proportion of psoriasis and atopic dermatitis patients who do not tolerate NB-UVB but demonstrate an excellent clinical response to BB-UVB. It is critical for dermatologists to recognize the role of BB-UVB as a complement to NB-UVB phototherapy for patients who cannot tolerate or experience an inadequate therapeutic response from NB-UVB.

Authors+Show Affiliations

University of California, Irvine School of Medicine, Irvine, CA, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

19895327

Citation

Pugashetti, Rupa, et al. "Broadband UVB Revisited: Is the Narrowband UVB Fad Limiting Our Therapeutic Options?" The Journal of Dermatological Treatment, vol. 21, no. 6, 2010, pp. 326-30.
Pugashetti R, Lim HW, Koo J. Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options? J Dermatolog Treat. 2010;21(6):326-30.
Pugashetti, R., Lim, H. W., & Koo, J. (2010). Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options? The Journal of Dermatological Treatment, 21(6), 326-30. https://doi.org/10.3109/09546630903341986
Pugashetti R, Lim HW, Koo J. Broadband UVB Revisited: Is the Narrowband UVB Fad Limiting Our Therapeutic Options. J Dermatolog Treat. 2010;21(6):326-30. PubMed PMID: 19895327.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options? AU - Pugashetti,Rupa, AU - Lim,Henry W, AU - Koo,John, PY - 2009/11/10/entrez PY - 2009/11/10/pubmed PY - 2011/2/2/medline SP - 326 EP - 30 JF - The Journal of dermatological treatment JO - J Dermatolog Treat VL - 21 IS - 6 N2 - Broadband ultraviolet B (BB-UVB) phototherapy has demonstrated efficacy in the treatment of cutaneous disorders including psoriasis, atopic dermatitis, uremic pruritus and idiopathic pruritus. In the last decade, there has been a rapidly escalating process of replacing BB-UVB phototherapy units with narrowband ultraviolet B (NB-UVB) equipment, as studies have demonstrated that NB-UVB (ranging from 311 mm to 312 nm) is more efficacious in the treatment of psoriasis. Nevertheless, it is important to recognize the efficacy of BB-UVB phototherapy in the treatment of uremic pruritus, idiopathic pruritus, eosinophilic folliculitis and other inflammatory pruritic conditions. Furthermore, as highlighted in this report, there is a small but significant proportion of psoriasis and atopic dermatitis patients who do not tolerate NB-UVB but demonstrate an excellent clinical response to BB-UVB. It is critical for dermatologists to recognize the role of BB-UVB as a complement to NB-UVB phototherapy for patients who cannot tolerate or experience an inadequate therapeutic response from NB-UVB. SN - 1471-1753 UR - https://www.unboundmedicine.com/medline/citation/19895327/Broadband_UVB_revisited:_is_the_narrowband_UVB_fad_limiting_our_therapeutic_options L2 - http://www.tandfonline.com/doi/full/10.3109/09546630903341986 DB - PRIME DP - Unbound Medicine ER -